Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W G Bensen

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
The Journal of Rheumatology|July 16, 1999
36 month intermittent cyclical etidronate treatment in patients with established corticosteroid induced osteoporosisR J Sebaldt, G Ioannidis, J D Adachi, et al.
Mayo Clinic Proceedings|November 24, 1999
Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trialW G Bensen, J J Fiechtner, J I McMillen, et al.
The New England Journal of Medicine|August 7, 1997
Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosisJ D Adachi, W G Bensen, J Brown, et al.
British Journal of Rheumatology|February 1, 1997
Salmon calcitonin nasal spray in the prevention of corticosteroid-induced osteoporosisJ D Adachi, W G Bensen, M J Bell, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|December 19, 2001
Positive effect of etidronate therapy is maintained after drug is terminated in patients using corticosteroidsJ P Brown, W P Olszynski, A Hodsman, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
The Journal of Rheumatology|July 16, 1999
36 month intermittent cyclical etidronate treatment in patients with established corticosteroid induced osteoporosisR J Sebaldt, G Ioannidis, J D Adachi, et al.
Mayo Clinic Proceedings|November 24, 1999
Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trialW G Bensen, J J Fiechtner, J I McMillen, et al.
The New England Journal of Medicine|August 7, 1997
Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosisJ D Adachi, W G Bensen, J Brown, et al.
British Journal of Rheumatology|February 1, 1997
Salmon calcitonin nasal spray in the prevention of corticosteroid-induced osteoporosisJ D Adachi, W G Bensen, M J Bell, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|December 19, 2001
Positive effect of etidronate therapy is maintained after drug is terminated in patients using corticosteroidsJ P Brown, W P Olszynski, A Hodsman, et al.
Pageof 5